Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.

MLA

Kamigaichi, Atsushi, et al. “Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.” The Annals of Thoracic Surgery, vol. 117, no. 4, Apr. 2024, pp. 743–51. EBSCOhost, https://doi.org/10.1016/j.athoracsur.2023.01.024.

APA

Kamigaichi, A., Mimae, T., Tsubokawa, N., Miyata, Y., Adachi, H., Shimada, Y., Ito, H., Ikeda, N., & Okada, M. (2024). Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma. The Annals of Thoracic Surgery, 117(4), 743–751. https://doi.org/10.1016/j.athoracsur.2023.01.024

Chicago

Kamigaichi, Atsushi, Takahiro Mimae, Norifumi Tsubokawa, Yoshihiro Miyata, Hiroyuki Adachi, Yoshihisa Shimada, Hiroyuki Ito, Norihiko Ikeda, and Morihito Okada. 2024. “Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.” The Annals of Thoracic Surgery 117 (4): 743–51. doi:10.1016/j.athoracsur.2023.01.024.